University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Green Beclometasone dipropionate

First line

Status: Green Beclometasone with Formoterol & Glycopyrronium (Trimbow®)

For COPD and asthma

Status: Red Bee and wasp allergen extracts (Phamalgen)

Hospital only

Status: Red Belatacept powder concentrate for infusion

For hospital use only

Status: Red Belimumab

Hospital use only

Status: Green Bendroflumethiazide tablets

2.5mg dose (higher doses not indicated in hypertension). Most patients do not develop hypokalaemia. Suggest check potassium level one month after initiation and annually thereafter (MeReC 10/94)

Status: Red Betaine anhydrous powder (180g)

NHSE commissioned.

Status: Amber Betamethasone 0.1%, neomycin 0.5% eye drops

Short term use only

Status: Green Betamethasone valerate 0.025% cream

Betnovate RD. Moderate potency.

Status: Green Betamethasone valerate 0.025% ointment

Betnovate RD. Moderate potency.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top